Agilent Technologies Unveils Altura Ultra Inert HPLC Columns, Achieving Breakthrough Sensitivity and Performance in Biotherapeutic Analysis
I'm PortAI, I can summarize articles.
Agilent Technologies Inc. has launched its Altura Ultra Inert HPLC columns, which significantly enhance analytical performance in biotherapeutic testing. These columns reportedly provide up to twice the sensitivity and three times the signal-to-noise ratio compared to competitors. When used with the Agilent 1290 Infinity III Bio LC, they can achieve up to 30 times higher peak area. The proprietary Ultra Inert technology improves conditioning, peak shapes, and sensitivity for challenging analytes like peptide GLP-1 and oligonucleotide therapeutics. This announcement was made on September 29, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments